medigraphic.com
Órgano Oficial del Instituto de Ciencias de la Salud, Hospital Escuela y Facultad de Medicina-Xalapa

2008, Number S3

<< Back Next >>

Rev Med UV 2008; 8 (S3)

Diagnóstico de tuberculosis multidrogoresistente mediante PCR en tiempo real

Zenteno CR

Language: Spanish
References: 45
Page: 17-19
PDF size: 180.51 Kb.


Text Extraction

No abstract


REFERENCES

  1. World Health Organization. WHO Site. Tuberculosis. Fact sheet N°104Revised 2007. Disponible en http://www.who.int/mediacentre/ factsheets/fs104/en/ [consultado 28 de Mayo 2007].

  2. Global Tuberculosis Control: Surveillance, Planning, Financing. WHO Report 2006, Geneva, World Health Organization (WHO/HTM/ TB/2006.362): 83-85.

  3. Tapia R. El Manual de Salud Pública. Unidad II. Capítulo 6 Tuberculosis. 2ªed. Editorial Intersistemas. México 2006. pp 469-505

  4. Zenteno R. Tópicos Selectos de la Salud Pública. Tuberculosis: realidades y perspectivas. Universidad Veracruzana. Instituto de Salud Pública. 2006. pp 9-28.

  5. Zumia A. Grange JM. 2001. Multidrug-resistant tuberculosis can the tide be turned?. Lancet Infect. Dis. 1:199–202.

  6. Quirós-Roldán E. Airoldi M. Moreti F. Carosi G. Bases moleculares de resistencia de Mycobacterium tuberculosis. Rev Diagn Biol. 2001; 50(4):25-32

  7. Caws M and Drobniewski. Molecular techniques in the diagnosis ofMycobacterium tuberculosis and the detection of drug resistence. Annals new York academy of sciences. London. 2001;953:138-145.

  8. Tanil Kocagoz Zeynep Saribas y Alpaslen Alp. Rapid determination of rifampin resistence in clinical isolates of Mycobacterium tuberculosis by real-time PCR. Journal of Clinical Microbiology. 2005; 43(12):6015- 6019

  9. García de Viedma. Rápid detecctión of resistance in Mycobacterium tuberculosis: a review discussing molecular aproaches. Europan Society of Clinical Microbilogy and Infectious Diseases. 2003; 9: 349- 359.

  10. Parashar. D. Chahuan D. Sharma V. Katoch V. Applications of real-time PCR technology to mycobacterial research. Indian J Med Res. 2006; 124:385-398.

  11. Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance. Expert Rev Mol Diagn. 2006; 6(3):423-32.

  12. Organización Panamericana de Salud. América Latina y el Caribe. Oficina de Información Pública, OPS. Washington DC - Estados Unidos. 2007. disponible en http://www.ops.org.bo/servicios/ ?DB=B&S11=12158&SE=SN [consultado 28 de Agosto 2008]

  13. Secretaria de Salud de Veracruz. Dirección general de epidemiologia. Casos de tuberculosis en la República Mexicana. 2006.

  14. Secretaria de Salud. Programa nacional de Salud 2007-2012.

  15. Servicios de Salud de Veracruz. Programa sectorial de salud 2005- 2010.

  16. Ramaswamy SV, Dou SJ, Rendon A, et al. Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico. J Med Microbiol. 2004; 53(2):107-13.

  17. Viader-Salvadó JM, Luna-Aguirre CM, Reyes-Ruiz JM, et al. Frequency of mutations in rpoB and codons 315 and 463 of katG in rifampinand/ or isoniazid-resistant Mycobacterium tuberculosis isolates from northeast Mexico. Microb Drug Resist. 2003;9(1):33-8.

  18. Alvarado C, Rossau R, Martinez S, et al. Characterization of rpoB gene

  19. mutaons in rifampin resistant Mycobacterium tuberculosis strains isolated from pulmonary tuberculosis paents at 5 Mexican public hospitals. Rev Invest Clin. 2001; 53(6): 526-530

  20. Granich RM, Balandrano S, Santaella AJ, et al. Survey of drug resistance of Mycobacterium tuberculosis in 3 Mexican states, 1997. Arch Intern Med. 2000; 160(5):639-44.

  21. Bobadilla del Valle M, Ponce-de-Leon A, Arenas-Huertero C, et al. rpoB Gene mutaons in rifampin-resistant Mycobacterium tuberculosis idenfied by polymerase chain reacon single-stranded conformaonal polymorphism. Emerg Infect Dis. 7(6):1010-1013.

  22. Naonal Survey on TB drugresistance, Mexico. Encuesta Nacional de Farmacorresistencia en tuberculosis, México 2008. PAHO/INDRE, México. (hp://www.mex.ops-oms.org/contenido/tuberculosis/ encuesta/. (12 July 2007, date last accessed).

  23. Telen A, Imboden P, Marchesi F, et al. Direct, automated detecon of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reacon and single-strand conformaon polymorphism analysis. Anmicrob Agents Chemother. 1993;37(10):2054-8.23.- Höfling CC, Pavan EM, Giampaglia CM, et al. Prevalen

  24. World Health Organization. WHO Site. Tuberculosis. Fact sheet N°104Revised 2007. Disponible en http://www.who.int/mediacentre/ factsheets/fs104/en/ [consultado 28 de Mayo 2007].

  25. Global Tuberculosis Control: Surveillance, Planning, Financing. WHO Report 2006, Geneva, World Health Organization (WHO/HTM/ TB/2006.362): 83-85.

  26. Tapia R. El Manual de Salud Pública. Unidad II. Capítulo 6 Tuberculosis. 2ªed. Editorial Intersistemas. México 2006. pp 469-505

  27. Zenteno R. Tópicos Selectos de la Salud Pública. Tuberculosis: realidades y perspectivas. Universidad Veracruzana. Instituto de Salud Pública. 2006. pp 9-28.

  28. Zumia A. Grange JM. 2001. Multidrug-resistant tuberculosis can the tide be turned?. Lancet Infect. Dis. 1:199–202.

  29. Quirós-Roldán E. Airoldi M. Moreti F. Carosi G. Bases moleculares de resistencia de Mycobacterium tuberculosis. Rev Diagn Biol. 2001; 50(4):25-32

  30. Caws M and Drobniewski. Molecular techniques in the diagnosis ofMycobacterium tuberculosis and the detection of drug resistence. Annals new York academy of sciences. London. 2001;953:138-145.

  31. Tanil Kocagoz Zeynep Saribas y Alpaslen Alp. Rapid determination of rifampin resistence in clinical isolates of Mycobacterium tuberculosis by real-time PCR. Journal of Clinical Microbiology. 2005; 43(12):6015- 6019

  32. García de Viedma. Rápid detecctión of resistance in Mycobacterium tuberculosis: a review discussing molecular aproaches. Europan Society of Clinical Microbilogy and Infectious Diseases. 2003; 9: 349- 359.

  33. Parashar. D. Chahuan D. Sharma V. Katoch V. Applications of real-time PCR technology to mycobacterial research. Indian J Med Res. 2006; 124:385-398.

  34. Pai M, Kalantri S, Dheda K. New tools and emerging technologies for the diagnosis of tuberculosis: part II. Active tuberculosis and drug resistance. Expert Rev Mol Diagn. 2006; 6(3):423-32.

  35. Organización Panamericana de Salud. América Latina y el Caribe. Oficina de Información Pública, OPS. Washington DC - Estados Unidos. 2007. disponible en http://www.ops.org.bo/servicios/ ?DB=B&S11=12158&SE=SN [consultado 28 de Agosto 2008]

  36. Secretaria de Salud de Veracruz. Dirección general de epidemiologia. Casos de tuberculosis en la República Mexicana. 2006.

  37. Secretaria de Salud. Programa nacional de Salud 2007-2012.

  38. Servicios de Salud de Veracruz. Programa sectorial de salud 2005- 2010.

  39. Ramaswamy SV, Dou SJ, Rendon A, et al. Genotypic analysis of multidrug-resistant Mycobacterium tuberculosis isolates from Monterrey, Mexico. J Med Microbiol. 2004; 53(2):107-13.

  40. Viader-Salvadó JM, Luna-Aguirre CM, Reyes-Ruiz JM, et al. Frequency of mutations in rpoB and codons 315 and 463 of katG in rifampinand/ or isoniazid-resistant Mycobacterium tuberculosis isolates from northeast Mexico. Microb Drug Resist. 2003;9(1):33-8.

  41. Alvarado C, Rossau R, Martinez S, et al. Characterization of rpoB gene mutaons in rifampin resistant Mycobacterium tuberculosis strains isolated from pulmonary tuberculosis paents at 5 Mexican public hospitals. Rev Invest Clin. 2001; 53(6): 526-530

  42. Granich RM, Balandrano S, Santaella AJ, et al. Survey of drug resistance of Mycobacterium tuberculosis in 3 Mexican states, 1997. Arch Intern Med. 2000; 160(5):639-44.

  43. Bobadilla del Valle M, Ponce-de-Leon A, Arenas-Huertero C, et al. rpoB Gene mutaons in rifampin-resistant Mycobacterium tuberculosis idenfied by polymerase chain reacon single-stranded conformaonal polymorphism. Emerg Infect Dis. 7(6):1010-1013.

  44. Naonal Survey on TB drugresistance, Mexico. Encuesta Nacional de Farmacorresistencia en tuberculosis, México 2008. PAHO/INDRE, México. (hp://www.mex.ops-oms.org/contenido/tuberculosis/ encuesta/. (12 July 2007, date last accessed).

  45. Telen A, Imboden P, Marchesi F, et al. Direct, automated detecon of rifampin-resistant Mycobacterium tuberculosis by polymerase chain reacon and single-strand conformaon polymorphism analysis. Anmicrob Agents Chemother. 1993;37(10):2054-8.23.- Höfling CC, Pavan EM, Giampaglia CM, et al. Prevalen




2020     |     www.medigraphic.com